Format

Send to

Choose Destination

See 1 citation found by title matching your search:

Eur J Pharmacol. 2011 Jun 11;660(1):165-70. doi: 10.1016/j.ejphar.2010.12.023. Epub 2011 Jan 3.

Successful methylphenidate treatment of early onset extreme obesity in a child with a melanocortin-4 receptor gene mutation and attention deficit/hyperactivity disorder.

Author information

1
Department of Child and Adolescent Psychiatry, University of Duisburg-Essen, Virchowstr. 174, D - 45147 Essen, Germany. oezguer.albayrak@uni-due.de

Abstract

We present the case report of a 2 year old boy with early onset extreme obesity (body mass index (BMI) 34.2 kg/m²; body mass index standard deviation score (BMI-SDS) 5.4) who is heterozygous for a non-conservative functionally relevant melanocortin MC(4)receptor mutation (Glu308Lys) and who also showed severe symptoms of attention deficit/hyperactivity disorder (ADHD). Treatment with the stimulant methylphenidate led to a sharp decrease of BMI to 21.8 kg/m² (BMI-SDS 2.8) within 24 months. We discuss potential mechanisms for this unusually large weight loss and suggest a potential link between the melanocortinergic and the dopaminergic systems, and the sympathetic nervous system. The potential benefit of methylphenidate in obese melanocortin MC(4)receptor mutation carriers with and without co-morbid ADHD warrants further studies.

PMID:
21211528
DOI:
10.1016/j.ejphar.2010.12.023
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center